MoneyWorks4Me

Themis Medicare informs about analyst meet

28 Sep 2021 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations) read with part A of Schedule Ill of the Listing Regulations, Themis Medicare has informed that the management of the Company had a one-on-one conference call with Analysts/ Investors on Monday, 27th September, 2021; as details enclosed. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the
website of the company viz. www.themismedicare.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..